Clindamycin for chronic prostatitis. Prostatita datorată enterococcus faecalis
Provides more in-depth coverage of epidemiology, etiology, pathology, microbiology, immunology, and treatment of infectious agents than any other infectious disease resource.
Features an increased focus on antibiotic stewardship; new clindamycin for chronic prostatitis for influenza, cytomegalovirus, hepatitis C, hepatitis B. Offers fully revised content on bacterial pathogenesis, antibiotic use and toxicity, the human microbiome and its effects on health and disease, immunological mechanisms and immunodeficiency, and probiotics and alternative approaches to treatment of infectious diseases.
Discusses up-to-date topics such as use of the new PCR panels for diagnosis of meningitis, diarrhea and pneumonia; current management of infected orthopedic implant infections; newly recognized infections transmitted by black-legged ticks in the USA: Borrelia miyamotoi and Powassan virus; infectious complications of new drugs for cancer; new drugs for resistant bacteria and mycobacteria; new guidelines for clindamycin for chronic prostatitis and therapy of HIV infections; and new vaccines against herpes zoster, influenza, meningococci.
PPID continues its tradition of including leading experts from a truly global community, including authors from Australia, Canada and countries in Europe, Asia, and South America.
Includes regular updates online for the life of the edition. Features more than 1, high-quality, full-color photographs-with hundreds new to this edition. Enhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices.